PharmPix Corp Revenue and Competitors

Location

N/A

Total Funding

Health

Industry

Estimated Revenue & Valuation

  • PharmPix Corp's estimated annual revenue is currently $31.3M per year.(i)
  • PharmPix Corp's estimated revenue per employee is $270,000

Employee Data

  • PharmPix Corp has 116 Employees.(i)
  • PharmPix Corp grew their employee count by 7% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.1M27-4%N/AN/A
#2
$6.5M30-12%N/AN/A
#3
$271.4M869N/AN/AN/A
#4
$26.2M97-5%N/AN/A
#5
$7.3M343%N/AN/A
#6
$89.1M30049%N/AN/A
#7
$7.1M330%N/AN/A
#8
$170.4M505-3%N/AN/A
#9
$9.7M45-4%N/AN/A
#10
$42.5M1435%N/AN/A
Add Company

PharmPix is a state-of-the-art pharmacy benefits information and management provider that saves your company costs by giving you back the power of decision. We offer innovative services for health plans and insurers, medium to large employers and union groups, private and government health programs, including Medicaid and Medicare. We pride ourselves in being super flexible, supporting any number of arrangements with our clients: from traditional third-party full pharmacy benefit management (PBM) service contracts to applications licensing agreements. We are “virtual” full service PBM with an adaptable business model for different pharmacy delivery solutions. PharmPix offers an innovative technology platform that effectively allows you to manage your pharmacy benefit costs: the OneArk™ Suite. Our technology platform serves the ever-changing needs of health insurance industry professionals. It is powerful, simple and cost-effective; setting a new standard in clinical intelligence technology. OneArk™ Suite also helps you grow a deeper connection to your beneficiaries and providers.

keywords:N/A

N/A

Total Funding

116

Number of Employees

$31.3M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$16.8M116N/AN/A
#2
$31.3M11632%N/A
#3
$146.6M116-3%$459.7M
#4
$20.9M1167%N/A
#5
$28.2M1165%N/A